Patient-Derived Organoids for Rectal Cancer

Duke University20 enrolled

Overview

The purpose of this study is to determine the feasibility of establishing patient-derived organoids from pre-treatment rectal adenocarcinoma biopsies.

Study Type

INTERVENTIONAL

Allocation

Purpose

OTHER

Masking

NONE

Enrollment

Conditions

Rectum Cancer

Interventions

BiopsyOTHER

Tissue biopsy

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion 1. Age ≥18 years old. 2. Able to provide informed consent. 3. Undergoing proctoscopy. Exclusion 1\. Patient not planned to receive neoadjuvant radiotherapy

Locations (1)

Duke Cancer Center

Durham, North Carolina, United States

Outcomes

Primary Outcomes

Number of Participants With Biopsies That Form Spherical Organoids

Time frame: Baseline

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.